Logo

Divi's Laboratories Ltd. Share Price

Pharmaceuticals & Drugs

Divi's Laboratories Ltd. (INR)5911.520   (0.3%)

Exchange ScripsBSE532488NSEDIVISLABISININE361B01024

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Divi's Laboratories Ltd. Performance

Market performance

Open price5884.5
High6018.5
Volumes666774
Prev Close5911.5
Low5823
Closing date2025-04-22

Historical performance

1 Year High6285.45
3 Year High6285.45
5 Year High6285.45
1 Year Low3724.00
3 Year Low2730.00
5 Year Low2090.05

Divi's Laboratories Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
156707
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
97.58
Dividend Yield
Dividend Yield
0.25 %

Divi's Laboratories Ltd. Investment Returns

1 Year
58.2%
3 Years
31.6%
5 Years
147.9%
10 Years
557.5%

Divi's Laboratories Ltd. Technicals

IndicatorsValueSignal
5-DMA5786.3Bullish
10-DMA5603.61Bullish
20-DMA5693.64Bullish
50-DMA5747.06Bullish
100-DMA5825.42Bullish
200-DMA5553.71Bullish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors267749280595278893298304347623
Government3321---

Divi's Laboratories Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income339034501159627
Operating Profit25450271403997029237
Interest40202021
Depreciation3780343031152556
Profit Before Tax21630236903683526660
Consolidated Net Profit16000182402960419843
Adjusted EPS606911275

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital530530531531
Total Reserves13518012714011675192415
Minority Interest------------
Total Non-Current Liabilities6110557043653639
Total Liabilities159370148630146191113869
Capital Work in Progress7780212046997106
Total Assets159370148630146191113869

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities12610245901911819469
Cash Flow from Investing Activities-2690-27070-21949751
Cash Flow from Financing Activitie-7990-7970-5324-349
Net Cash Inflow / Outflow1930-10450-815619872
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 97.58.
  • 3Y Stock Price CAGR of the stock is 9.5.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹25450 Million.
  • The company generated revenue of ₹78450 Million in the previous financial year.

Divi's Laboratories Ltd.

5911.520   (0.3%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1568598.8
No. of Shares: 265.3
Performance:56.9%
P/L: ₹568598.8

Top Gainers

SymbolChange%
MANAKSTEEL60.18(20%)
INDOWIND21.68(20%)
VASWANI46.9(20%)
AGRITECH172.89(20%)
RAJRATAN390.15(20%)

Top Losers

SymbolChange%
JINDRILL736.5(-8%)
GNA347.8(-7%)
AFIL7.95(-6%)
TPHQ1.16(-6%)
SANGHVIMOV299.52(-6%)
EUROTEXIND14.62(-6%)
CHOLAFIN1566.4(-6%)
SMLISUZU1781(-5%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

51.5

57.91

March 22 - April 22

SMS Lifesciences India Ltd.

50.4

1625.8

March 22 - April 22

Hester Biosciences Ltd.

29.7

1801.6

March 22 - April 22

Sakar Healthcare Ltd.

28.7

309.22

March 22 - April 22

Natural Capsules Ltd.

25.7

222.82

March 22 - April 22

Valiant Laboratories Ltd.

24

105.29

March 22 - April 22

Bal Pharma Ltd.

22.7

109.54

March 22 - April 22

Gujarat Themis Biosyn Ltd.

19.7

304.55

March 22 - April 22

Announcing Stock of the Month!

Stock of the Month
Stock of the Month